Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) Sees Significant Growth in Short Interest

Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) was the target of a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 45,023 shares, an increase of 38.3% from the November 30th total of 32,560 shares. Based on an average trading volume of 30,871 shares, the short-interest ratio is currently 1.5 days. Based on an average trading volume of 30,871 shares, the short-interest ratio is currently 1.5 days.

Medexus Pharmaceuticals Stock Up 0.2%

MEDXF traded up $0.00 on Tuesday, hitting $2.13. The company had a trading volume of 21,368 shares, compared to its average volume of 18,681. Medexus Pharmaceuticals has a 1-year low of $1.43 and a 1-year high of $3.88. The company’s fifty day moving average price is $1.94 and its 200 day moving average price is $2.06.

About Medexus Pharmaceuticals

Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.

Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late?stage and marketed assets, then manages their regulatory approval and commercialization.